Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 1052Neoplasms 886Prostatic Neoplasms 505Lung Neoplasms 422Colorectal Neoplasms 350Motor Activity 221Head and Neck Neoplasms 191Uterine Cervical Neoplasms 186Carcinoma, Non-Small-Cell Lung 180Brain Neoplasms 168Pancreatic Neoplasms 162Ovarian Neoplasms 139Colonic Neoplasms 138Carcinoma, Hepatocellular 134Anxiety Disorders 124Rectal Neoplasms 118Hematologic Neoplasms 114Multiple Myeloma 107Stomach Neoplasms 102Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 96Melanoma 92Depression 92Urinary Bladder Neoplasms 88Pain 88Endometrial Neoplasms 85Lymphoma 83Disease 83Glioblastoma 79Gastrointestinal Neoplasms 78

Interventions

Speech Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Communication Disorders × 1 year × Clear all
NCT04969874 2026-05-12

E-CRIL_MAX

University Hospital, Toulouse

Phase NA Withdrawn

Communication Disorders

NCT05189366 2026-04-14

SOPHNEURO

Institut Cancerologie de l'Ouest

Phase NA Terminated
13 enrolled 8 charts
CNS

Communication Disorders, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡